Lavender KJ - Search Results

1

Kane KP, Lavender KJ, Ma BJ. Kane KP, et al. Among authors: lavender kj. Crit Rev Immunol. 2004;24(5):321-48. doi: 10.1615/critrevimmunol.v24.i5.20. Crit Rev Immunol. 2004. PMID: 15663362 Review.

2

Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands.

Silver ET, Lavender KJ, Gong DE, Hazes B, Kane KP. Silver ET, et al. Among authors: lavender kj. J Immunol. 2002 Nov 1;169(9):4752-60. doi: 10.4049/jimmunol.169.9.4752. J Immunol. 2002. PMID: 12391184

3

The rat RT1-A1c MHC molecule is a xenogeneic ligand recognized by the mouse activating Ly-49W and inhibitory Ly-49G receptors.

Lavender KJ, Ma BJ, Silver ET, Kane KP. Lavender KJ, et al. J Immunol. 2004 Mar 15;172(6):3518-26. doi: 10.4049/jimmunol.172.6.3518. J Immunol. 2004. PMID: 15004152

4

Cross-species dependence of Ly49 recognition on the supertype defining B-pocket of a class I MHC molecule.

Lavender KJ, Kane KP. Lavender KJ, et al. J Immunol. 2006 Dec 15;177(12):8578-86. doi: 10.4049/jimmunol.177.12.8578. J Immunol. 2006. PMID: 17142756

5

Distinctive interactions at multiple site 2 subsites by allele-specific rat and mouse ly49 determine functional binding and class I MHC specificity.

Lavender KJ, Chau HH, Kane KP. Lavender KJ, et al. J Immunol. 2007 Nov 15;179(10):6856-66. doi: 10.4049/jimmunol.179.10.6856. J Immunol. 2007. PMID: 17982076

6

Determining ligand specificity of Ly49 receptors.

Lavender KJ, Kane KP. Lavender KJ, et al. Methods Mol Biol. 2010;612:299-311. doi: 10.1007/978-1-60761-362-6_20. Methods Mol Biol. 2010. PMID: 20033649

7

Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice.

Rout SS, Di Y, Dittmer U, Sutter K, Lavender KJ. Rout SS, et al. Among authors: lavender kj. AIDS. 2022 Mar 1;36(3):325-336. doi: 10.1097/QAD.0000000000003111. AIDS. 2022. PMID: 35084382

8

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.

Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, Kappes JC, Ferrari G, Kessels L, Williams I; CHAVI Clinical Core B; McMichael AJ, Haynes BF, Borrow P, Colonna M; NIAID Center for HIV/AIDS Vaccine Immunology. Cella M, et al. Eur J Immunol. 2010 Apr;40(4):949-54. doi: 10.1002/eji.200940234. Eur J Immunol. 2010. PMID: 20201043 Free PMC article.

9

BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.

Lavender KJ, Pang WW, Messer RJ, Duley AK, Race B, Phillips K, Scott D, Peterson KE, Chan CK, Dittmer U, Dudek T, Allen TM, Weissman IL, Hasenkrug KJ. Lavender KJ, et al. Blood. 2013 Dec 12;122(25):4013-20. doi: 10.1182/blood-2013-06-506949. Epub 2013 Sep 10. Blood. 2013. PMID: 24021673 Free PMC article.

10

No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.

Van Dis ES, Moore TC, Lavender KJ, Messer RJ, Keppler OT, Verheyen J, Dittmer U, Hasenkrug KJ. Van Dis ES, et al. Among authors: lavender kj. Virology. 2016 Jan 15;488:88-95. doi: 10.1016/j.virol.2015.11.005. Epub 2015 Nov 21. Virology. 2016. PMID: 26609939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page